Gilead Sciences, Inc. (GILD.MX)
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
2,301.25+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+7.3%
The outlook
Gilead Sciences, Inc. currently reads as neutral based on mixed vs its moving averages, 47% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range47% of the way from its 52-week low to high
Market cap
$2.86T
52-wk high
2,618.71
52-wk low
2,025.32
50-day avg
2,238.89
200-day avg
2,325.91
Trailing P/E
18.0